🇺🇸 FDA
Pipeline program

trofosfamide, idarubicin, etoposide

CWS-2007-HR

Phase 3 small_molecule completed

Quick answer

trofosfamide, idarubicin, etoposide for Soft Tissue Sarcoma is a Phase 3 program (small_molecule) at Solid Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Solid Biosciences
Indication
Soft Tissue Sarcoma
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials